In addition to the above, given that COVID-19 is a viral infection, the role of CD8+ T cells has been examined and found to be protective, and it may be even more important in patients with hematological malignancies who have impaired humoral responses [152,153]. This evidence concerns the gene CD8A and viral infectious disease.